<div class="embed-responsive embed-responsive-16by9"><iframe width="640" height="360" style="max-width: 100%;max-height: 100%; border:none;" src="https://oncologytube.com/videoEmbed/28745/combo-ipilimumab-nivolumab-in-histologies-of-bladder-cancer?channelName=obr&modestbranding=1&showinfo=1&autoplay=&controls=1&loop=&mute=&t=0&objectFit=" frameborder="0" allowfullscreen="allowfullscreen" allow="autoplay" scrolling="no">iFrame is not supported!</iframe></div>

Combo Ipilimumab + Nivolumab in Histologies of Bladder Ca...

Name: Combo Ipilimumab + Nivolumab in Histologies of Bladder Ca...
Uploaded: 2019-07-01T05:17:39
Duration: 1 min 28 s
Description: Bradley McGregor MD, Instructor, Medicine, Harvard Medical School, Clinical Director, Lank Center for Genitourinary Oncology, GU Network Liaison, Dana Farber Cancer Institute offers his insight on the combination of ipilimumab + nivolumab in histologies of bladder cancer.

Combo Ipilimumab + Nivolumab in Histologies of Bladder Cancer

00:01:28

Don

3 years 65 Views

Share Add to Report 0 0

Embed (Iframe):

<div class="embed-responsive embed-responsive-16by9"><iframe width="640" height="360" style="max-width: 100%;max-height: 100%; border:none;" src="https://oncologytube.com/videoEmbed/28745/combo-ipilimumab-nivolumab-in-histologies-of-bladder-cancer?channelName=obr&modestbranding=1&showinfo=1&autoplay=&controls=1&loop=&mute=&t=0&objectFit=" frameborder="0" allowfullscreen="allowfullscreen" allow="autoplay" scrolling="no">iFrame is not supported!</iframe></div>

Embed (Object):

<div class="embed-responsive embed-responsive-16by9"><object width="640" height="360"><param name="movie" value="https://oncologytube.com/videoEmbed/28745/combo-ipilimumab-nivolumab-in-histologies-of-bladder-cancer?channelName=obr&modestbranding=1&showinfo=1&autoplay=&controls=1&loop=&mute=&t=0&objectFit="></param><param name="allowFullScreen" value="true"></param><param name="allowscriptaccess" value="always"></param><embed src="https://oncologytube.com/videoEmbed/28745/combo-ipilimumab-nivolumab-in-histologies-of-bladder-cancer?channelName=obr&modestbranding=1&showinfo=1&autoplay=&controls=1&loop=&mute=&t=0&objectFit=" allowscriptaccess="always" allowfullscreen="true" width="640" height="360"></embed></object></div>

Link (HTML):

<a href="https://oncologytube.com/v/28745?channelName=obr"><img src="https://oncologytubecom.cdn.ypt.me/videos/video_190701171739_59a4/video_190701171739_59a4.jpg?cache=15669161071678829655">Combo Ipilimumab + Nivolumab in Histologies of Bladder Cancer</a>

Link (BBCode):

[url=https://oncologytube.com/v/28745?channelName=obr][img]https://oncologytubecom.cdn.ypt.me/videos/video_190701171739_59a4/video_190701171739_59a4.jpg?cache=15669161071678829655[/img]Combo Ipilimumab + Nivolumab in Histologies of Bladder Cancer[/url]

Sign in now!

Permanent Link

URL Friendly (SEO)

Current Time (SEO)

Category:

Bladder

Description:

Bradley McGregor MD, Instructor, Medicine, Harvard Medical School, Clinical Director, Lank Center for Genitourinary Oncology, GU Network Liaison, Dana Farber Cancer Institute offers his insight on the combination of ipilimumab + nivolumab in histologies of bladder cancer.